OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert BNTX.../  DE000ME5DLF8  /

Stuttgart
17/05/2024  21:50:22 Chg.-1.84 Bid22:00:35 Ask22:00:35 Underlying Strike price Expiration date Option type
83.24EUR -2.16% -
Bid Size: -		 -
Ask Size: -		 BioNTech SE - USD 28/06/2024 Call
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 17/05 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire 09/05 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 06/05 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 06/05 Europe mixed premarket with data on the limelight
GlobeNewswire 02/05 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 10/04 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 04/04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 28/03 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 27/03 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
TeleTrader 20/03 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
TeleTrader 20/03 Europe mixed premarket amid data
GlobeNewswire 14/03 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 12/03 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire 11/03 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 11/03 FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead ...
GlobeNewswire 11/03 DEADLINE ALERT for DADA, BNTX, and CMI: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 11/03 BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline ...
GlobeNewswire 11/03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 11/03 BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Sub...